Welcome to our dedicated page for RESIDEO TECHNOLOGIES SEC filings (Ticker: REZI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on RESIDEO TECHNOLOGIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into RESIDEO TECHNOLOGIES's regulatory disclosures and financial reporting.
Clayton, Dubilier & Rice (CD&R) reported an 18.3% beneficial stake in Resideo Technologies (Common Stock) through related Cayman entities. The filing shows CD&R Channel Holdings II, L.P. directly holds 12,132,567 shares and 498,500 shares of Series A Preferred Stock held by CD&R Channel Holdings are convertible into 18,517,830 common shares at an initial conversion price of $26.92, producing an aggregate reported beneficial ownership of 30,650,397 shares, equal to 18.3% of a 167,281,233 share base used for calculation. CD&R Channel Holdings alone is reported as owning an 11.1% as-converted interest. The amendment discloses recent open-market purchases by CD&R Holdings II on multiple dates in August 2025 totaling several hundred thousand shares at prices ranging roughly from $27.08 to $32.00. The filing includes an undertaking to provide detailed per-price purchase data to the issuer or the SEC staff.
Resideo Technologies insider sale: Jay L. Geldmacher, who serves as President and CEO and is also a director, reported the sale of 47,500 shares of Resideo common stock on 08/12/2025. The shares were sold in multiple transactions at prices ranging from $30.82 to $31.44, producing a weighted-average price of $31.2902. After the sale, Geldmacher beneficially owned 519,689 shares. The Form 4 was signed by an attorney-in-fact, Jeannine J. Lane, on 08/14/2025. The filing records a direct disposition and does not include derivative transactions.
Insider exercise and share withholding by Resideo executive. Stephen M. Kelly, EVP and Chief HR Officer of Resideo Technologies (REZI), reported option activity on 08/12/2025. He exercised fully vested stock options with a $24.39 exercise price for 38,053 shares; the filing shows those options were exercisable through 02/10/2026. To satisfy the exercise price and tax withholding, the issuer withheld 32,970 shares at an implied price of $31.28. After these transactions the report lists 233,289 shares beneficially owned by Mr. Kelly (direct ownership). The option grant that produced the exercised shares is described as fully vested, and the Form 4 was signed by an attorney-in-fact on 08/14/2025.
Jeannine J. Lane, Resideo Technologies (REZI) EVP, General Counsel and Corporate Secretary, reported option exercise and contemporaneous sale on 08/12/2025. The filing shows Lane exercised a stock option with a $24.39 exercise price for 35,398 shares and immediately sold 35,398 shares at a weighted average price of $31.312. After these transactions, the filing reports Lane beneficially owned 155,136 shares (down from 190,534 before the sale); the prior balance included 352 shares that were omitted in earlier Form 4s. The Form notes the option was fully vested and provides the sale price range of $31.31 to $31.345.
Resideo Technologies completed a transaction that terminated a long‑standing indemnification and reimbursement arrangement with Honeywell in exchange for a one‑time $1,590,000,000 cash payment. The termination eliminated Resideo’s obligation to make annual payments to Honeywell of up to $140 million through year‑end 2043 and removed the affirmative and negative covenants under that agreement, subject only to limited provisions that survived termination.
To fund part of the payment, Resideo amended its existing credit facilities and obtained incremental senior secured term loans totaling $1.225 billion with a seven‑year maturity and interest at Term SOFR plus 2.00%. The amendment also raised the interest on certain existing term B tranches from Term SOFR plus 1.75% to Term SOFR plus 2.00%, increased capacity to incur incremental debt, temporarily relaxed the total leverage covenant to 4.00:1.00 for two upcoming test periods, and permits future revolver refinancings.
Resideo Technologies insider transaction summary The Form 4 reports that CD&R-affiliated entities, identified as a director and greater-than-10% owner, purchased a total of 1,246,123 shares of Resideo Technologies, Inc. (REZI) across transactions dated 08/08/2025, 08/11/2025 and 08/12/2025. The filing shows weighted-average prices for the five reported lots of $27.3003, $27.3366, $30.0345, $30.9423 and $31.4902, and footnotes disclose the price ranges for each lot.
Following these purchases the reporting persons' disclosed beneficial ownership rose to 11,478,543 shares. The securities are owned directly by CD&R Channel Holdings II, L.P., with CD&R Investment Associates XII, Ltd. and CD&R Associates XII, L.P. identified as affiliated entities that may be deemed to beneficially own the reported securities.
Resideo Technologies insider filing: Michael Carlet, the company's Chief Financial Officer, reported a purchase of 1,540 shares of Resideo Technologies, Inc. (REZI) on 08/09/2025 at a reported price of $27.37 per share. Following the transaction his beneficial ownership is reported as 160,861 shares. The transaction is recorded on a Form 4 and is shown with transaction code F.
Resideo Technologies, Inc. filed a Form 144 reporting a proposed sale of 35,398 common shares through Morgan Stanley Smith Barney on 08/12/2025. The filing lists an aggregate market value of $1,108,378.64 against 148,763,403 shares outstanding, and names the NYSE as the exchange. The notice shows the shares were acquired by a stock option exercise on 08/12/2025 and payment was made in cash.
The filer indicates there were no securities sold by the person in the past three months. Other identifying details for the filer and the issuer (such as specific names or relationship descriptions) are not provided in the text of this filing. The form includes the standard representation that the seller is not aware of undisclosed material adverse information.
Resideo Technologies (REZI) filed a Form 144 disclosing a proposed sale of 47,500 shares of common stock, with an aggregate market value of $1,486,279.75, to be sold on the NYSE through Morgan Stanley Smith Barney LLC with an approximate sale date of 08/12/2025. The filing shows total shares outstanding of 148,763,403, and states there were no securities sold in the past three months by the selling person.
The securities offered were received as restricted stock in three lots dated 02/18/2023 (19,446 shares), 02/18/2024 (2,592 shares) and 02/09/2025 (25,462 shares). The filer affirms they are not aware of any undisclosed material adverse information about the issuer.
Boston Partners filed a Schedule 13G/A reporting beneficial ownership of Resideo Technologies common stock. The firm reports ownership of 8,394,667 shares, representing 5.65% of the outstanding class, and may be deemed a beneficial owner under the Exchange Act.
The filing shows Boston Partners has sole voting power over 6,669,489 shares and sole dispositive power over 8,394,667 shares. The shares are held in discretionary client accounts and the filer certifies the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.